Suprachoroidal space (SCS) injection is an exciting method for the targeted delivery of therapies directly adjacent to affected chorioretinal tissues, potentially addressing several unmet needs in ...

He advised paying particular attention to the incision because of the potential for vitreous hemorrhage closure by lasering the area around the incision. At the end of the case, he also advised that ...

Clearside Biomedical, Inc. has announced that its suprachoroidal injection delivery platform will be prominently featured at the Clinical Trials at the Summit (CTS) Meeting on June 21, 2025, in ...

- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine ...

NASHVILLE — A bleeding disorder in babies that is so rare that it typically affects fewer than one in 100,000 newborns is becoming more common in Tennessee because parents are refusing vitamin K ...

Nonaneurysmal Subarachnoid Hemorrhage: A Review of Clinical Course and Outcome in Two Hemorrhage Patterns Linda L. Herrmann; Joseph M. Zabramski Disclosures J Neurosci Nurs. 2007;39 (6):135-142.

ALPHARETTA, Ga., June 17, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...

Introduction Subarachnoid hemorrhage (SAH) is an acute cerebrovascular event with profound effects on the CNS and several other organs. SAH occurs with an incidence of two to 22.5 cases per ...

HONG KONG and WENZHOU, China, June 9, 2025 /PRNewswire/ -- VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs ...

Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS ...